Vuzix (NASDAQ:VUZI – Get Free Report) is scheduled to release its earnings data after the market closes on Thursday, May 9th. Persons that are interested in registering for the company’s earnings conference call can do so using this link.
Vuzix (NASDAQ:VUZI – Get Free Report) last posted its earnings results on Monday, April 15th. The company reported ($0.32) earnings per share for the quarter. The firm had revenue of $1.07 million during the quarter. Vuzix had a negative net margin of 413.47% and a negative return on equity of 51.52%.
Vuzix Stock Performance
NASDAQ:VUZI traded down $0.02 on Tuesday, hitting $1.28. The stock had a trading volume of 82,196 shares, compared to its average volume of 698,606. The company has a fifty day moving average price of $1.37 and a two-hundred day moving average price of $1.90. Vuzix has a 1-year low of $1.10 and a 1-year high of $6.06.
Insider Buying and Selling at Vuzix
Analysts Set New Price Targets
Separately, Craig Hallum decreased their target price on shares of Vuzix from $3.50 to $3.00 and set a “buy” rating on the stock in a report on Tuesday, April 16th.
Check Out Our Latest Report on Vuzix
Vuzix Company Profile
Vuzix Corporation, together with its subsidiaries, designs, manufactures, markets, and sells augmented reality (AR) wearable display and computing devices in North America, Europe, the Asia-Pacific, and internationally. It provides monocular smart glasses for enterprise, industrial, commercial, defense and security, and medical markets; Vuzix Z100, Vuzix Blade, and Vuzix Shield smart glasses; original equipment manufacturer waveguide optics and display engines; and Mobilium logistics mobility software, which removes traditional middleware, and supports various ERP systems and modern-day warehouse picking with wearable devices, as well as custom solutions and engineering solutions.
See Also
- Five stocks we like better than Vuzix
- What are earnings reports?
- Freshpet Surges 10%: Fresh Highs to Come for This Pet Stock
- How to Read Stock Charts for Beginners
- Hims & Hers Health Stock Could Become a Wealth Compounder
- What Percentage Gainers Tell Investors and Why They Don’t Tell the Whole Story
- 3 Penny Stocks That Insiders Are Buying
Receive News & Ratings for Vuzix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vuzix and related companies with MarketBeat.com's FREE daily email newsletter.